Revvity, Inc. (RVTY) is a Massachusetts-based life sciences and diagnostics company formed in 2023. It provides instruments, ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held ...

On Monday, Revvity Inc. (NYSE:RVTY) reported second-quarter sales of $691.69 million, down from $709.07 million, beating the consensus of $690.36 million. The life sciences and diagnostics company ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2025 investor letter. A ...

Revvity, Inc. RVTY is slated to report fourth-quarter 2024 results on Jan. 31, before market open. In the last reported quarter, the company delivered an earnings surprise of 13.27%. RVTY’s earnings ...

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today announced a new license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for the technology underlying its Pin-point™ base editing ...

Shares of Revvity (NYSE:RVTY) hit a 52-week low and led shares of fellow life science tool and services providers lower on Friday after the company released a disappointing Q3 earnings report and cut ...

Revvity Inc. (NYSE:RVTY) stock is trading higher on Monday after the company reported better-than-expected first-quarter 2025 earnings. The Waltham, Massachusetts-based company reported first-quarter ...

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (RVTY) (NYSE: RVTY), today announced it will host an Investor Day on Thursday, November 21, 2024 at 9:00 a.m. PT which will feature presentations by ...

Revvity, the former life-sciences and diagnostics business of the company previously known as PerkinElmer, is stepping up investments in software and research as it works to shape its new identity ...